acrolein has been researched along with Cancer of Ovary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, H; Ding, D; Gong, S; Hong, Z; Huang, FP; Huang, S; Liang, H; Zhong, J; Zhong, Q | 1 |
| Ahn, S; Cho, HJ; Hwang, D; Hyun, J; Jung, H; Koh, D; Lee, YH; Lim, Y; Shin, SY; Yong, Y; Yoon, H | 1 |
| Artemyev, MV; Baranov, AV; Deyev, SM; Generalova, AN; Oleinikov, VA; Sizova, SV; Zarifullina, MM; Zdobnova, TA; Zubov, VP | 1 |
3 other study(ies) available for acrolein and Cancer of Ovary
| Article | Year |
|---|---|
A triphenylphosphine coordinated cinnamaldehyde-derived copper(I) Fenton-like agent with mitochondrial aggregation damage for chemodynamic therapy.
Topics: Acrolein; Cell Line, Tumor; Coordination Complexes; Copper; Female; Humans; Hydrogen Peroxide; Organophosphorus Compounds; Ovarian Neoplasms | 2022 |
Polyphenols bearing cinnamaldehyde scaffold showing cell growth inhibitory effects on the cisplatin-resistant A2780/Cis ovarian cancer cells.
Topics: Acrolein; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Molecular Structure; Ovarian Neoplasms; Polyphenols; Structure-Activity Relationship | 2014 |
Submicron polymer particles containing fluorescent semiconductor nanocrystals CdSe/ZnS for bioassays.
Topics: Acrolein; Biosensing Techniques; Cadmium Compounds; Cell Line, Tumor; Female; Fluorescent Dyes; Fluoroimmunoassay; Humans; Immunoconjugates; Nanoparticles; Nanotechnology; Ovarian Neoplasms; Plague; Polymers; Selenium Compounds; Semiconductors; Sulfides; Yersinia pestis; Zinc Compounds | 2011 |